Talks from Professor Taka-Aki Sato & Professor Yasuhiro Yasutomi
Special Lectures to students / CPM members and the general biomedical community in Oxford by high-profile visitors from Japan
Monday 27 March 18:00 – 20:00, Mary Ogilvie Lecture Theatre, St Anne’s College, Oxford.
Refreshments will be served after the lectures.
This event is free and no sign-up is needed.
http://www.well.ox.ac.uk/cpm/talks-from-professor-taka-aki-sato-and-professor-yasuhiro-yasutomi
Leading-Edge Applications of Mass Spectrometry in Drug Discovery and Diagnosis
Professor Taka-Aki Sato, Director of the R&D Center for Precision Medicine, University of Tsukuba, Japan
Driven by the development of high-end mass spectrometers, proteome & metabolome analysis are currently expanding to single-cell imaging and characterization of heterogeneity in post-translational modification. The main topics of this seminar include: (1) visualization of molecular abundance in biological specimens by mass spectrometry imaging (MSI); (2) high-sensitivity detection of diagnostic markers by Immuno-Beads MS technology; and (3) a brief introduction to the development of next-generation mass spectrometry system for contribution in drug discovery and diagnosis field.
Nonhuman Primates Resource for Medical Science in Tsukuba Primate Research Center, Japan
Professor Yasuhiro Yasutomi, Director of Tsukuba Primate Research Center (TPRC), National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN) and Department of Immunoregulation, Graduate School of Medicine, Mie University, Japan
Nonhuman primates (NHP) are critical resources for biomedical research. Cynomolgus monkeys are one of the key nonhuman primate models that share nearly all characteristics with humans. Tsukuba Primate Research Center (TPRC) in National Institutes of Biomedical innovation, Health and Nutrition (NIBIOHN) Japan has a large-scale breeding colony of experimental monkeys (approximately 1,6000 monkeys), which play a significant role in the development of pharmaceutical products and medical technologies. The center is the forefront facility in Japan that both supplies laboratory-bred monkeys, mainly cynomolgus monkeys, and performs medical research. Cynomolgus monkeys have been maintained in indoor facilities as closed colony monkeys in TPRC since 1978. In addition to quality control, supply, research resource development, and basic technology development involving the experimental monkeys, evaluation of state-of-the-art medical technology, evaluation of the efficacy of new drugs and safety assessments are also performed using the monkeys. TPRC proactively to develop model animals for these diseases by artificial manipulation such as infectious disease. Moreover, some spontaneous diseases have been found during such health examinations, and the familial progress of diseases such as macular degeneration, dilated cardiomyopathy, endometriosis, senile plaque formation, hyperlipidemia, and diabetes has been confirmed. Since cynomolgus monkeys have a long life span and can be used for longevity studies such as those focused on Alzheimer disease using aged animals that are more than 20 years old, which correspond to ≥60 years of age in humans. I will introduce TPRC for new proposal of NHP study in medical science field.
Date:
27 March 2017, 18:00 (Monday, 11th week, Hilary 2017)
Venue:
St Anne's College, Woodstock Road OX2 6HS
Venue Details:
Mary Ogilvie Lecture Theatre
Speakers:
Professor Taka-Aki Sato (University of Tsukuba, Japan),
Professor Yasuhiro Yasutomi (Mie University, Japan)
Organising department:
Wellcome Trust Centre for Human Genetics
Organisers:
Catherine Lidbetter (Centre for Personalised Medicine),
Thea Perry (Centre for Personalised Medicine)
Organiser contact email address:
cpm@well.ox.ac.uk
Part of:
Centre for Personalised Medicine Seminars
Booking required?:
Not required
Cost:
Free
Audience:
Public
Editor:
Thea Perry
